Calcitonin gene-related peptide-induced suppression of luteinizing hormone pulses in the rat: The role of endogenous opioid peptides

Journal of Physiology

Volumn 566, Issue 3, 2005, Pages 921-928

  Bowe, James E ^a,c   Li, X F ^a   Kinsey Jones, J S ^a   Paterson, S ^a   Brain, S D ^a   Lightman, S L ^b   O'Byrne, K T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; LUTEINIZING HORMONE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE DERIVATIVE; ENDORPHIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN VENTRICLE; CONTROLLED STUDY; FEMALE; HORMONE INHIBITION; LUTEINIZING HORMONE RELEASE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; PULSATILE HORMONE RELEASE; RAT; VEIN CATHETERIZATION; ADULT; HORMONAL REGULATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 23744440806     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.085662     Document Type: Article

References (48)

1. Almeida OF, Nikolarakis KE & Herz A (1988). Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor. Endocrinology 122, 1034-1041.
2. Bonavera JJ, Kalra SP & Kalra PS (1993). Mode of action of interleukin-1 in suppression of pituitary LH release in castrated male rats. Brain Res 612, 1-8.
3. Brain SD, Williams TJ, Tippins JR, Morris HR & MacIntyre I (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 54-56.
4. Cagampang FR, Cates PS, Sandhu S, Strutton PH, McGarvey C, Coen CW & O'Byrne KT (1997). Hypoglycaemia-induced inhibition of pulsatile luteinizing hormone secretion in female rats: role of oestradiol, endogenous opioids and the adrenal medulla. J Neuroendocrinol 9, 867-872.
5. Cagampang FR & Maeda K (1991). Effects of intracerebroventricular administration of opiate receptor antagonists on the suppressed pulsatile LH release during acute fasting in ovariectomized estradiol-treated rats. Life Sci 49, 1823-1828.
6. Campbell RE, Han SK & Herbison AE (2005). Biocytin filling of adult GnRH neurons in situ reveals extensive, spiny, dendritic processes. Endocrinology 146, 1163-1169.
7. Cates PS, Forsling ML & O'Byrne KT (1999). Stress-induced suppression of pulsatile luteinising hormone release in the female rat: role of vasopressin. J Neuroendocrinol 11, 677-683.
8. Chen M, Lee J, Huang BS, Grekin RJ & Malvin RL (1989). Clonidine and morphine increase atrial natriuretic peptide secretion in anesthetized rats. Proc Soc Exp Biol Medical 191, 299-303.
9. Corbett AD, Paterson SJ & Kosterlitz HW (1993). Selectivity of ligands for opioid receptors. Handbook Exp Pharmacol 104, 645-679.
10. Dhillo WS, Small CJ, Jethwa PH, Russell SH, Gardiner JV, Bewick GA, Seth A, Murphy KG, Ghatei MA & Bloom SR (2003). Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary- adrenal axis. Endocrinology 144, 1420-1425.
11. Ehlers CL, Somes C, Li TK, Lumeng L, Hwang BH, Jimenez P & Mathe AA (1999). Calcitonin gene-related peptide (CGRP) levels and alcohol. Int J Neuropsychopharmacol 2, 173-179.
12. Fisher LA, Kikkawa DO, Rivier JE, Amara SG, Evans RM, Rosenfeld MG, Vale WW & Brown MR (1983). Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature 305, 534-536.
13. Gindoff PR & Ferin M (1987). Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate. Endocrinology 121, 837-842.
14. Giri M & Kaufman JM (1994). Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig. Endocrinology 135, 2137-2143.
15. Grosser PM, O'Byrne KT, Williams CL, Thalabard JC, Hotchkiss J & Knobil E (1993). Effects of naloxone on estrogen-induced changes in hypothalamic gonadotropin-releasing hormone pulse generator activity in the rhesus monkey. Neuroendocrinology 57, 115-119.
16. Ishihara S, Tsuchiya S, Horie S, Murayama T & Watanabe K (2001). Stimulatory effects of centrally injected kappa-opioid receptor agonists on gastric acid secretion in urethane-anesthetized rats. Eur J Pharmacol 418, 187-194.
17. Jarry H, Leonhardt S & Wuttke W (1995). The inhibitory effect of beta-endorphin on LH release in ovariectomized rats does not involve the preoptic GABAergic system. Exp Clin Endocrinol Diabetes 103, 317-323.
18. Kalra A, Urban MO & Sluka KA (2001). Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther 298, 257-263.
19. Kesner JS, Kaufman JM, Wilson RC, Kuroda G & Knobil E (1986). The effect of morphine on the electrophysiological activity of the hypothalamic luteinizing hormone-releasing hormone pulse generator in the rhesus monkey. Neuroendocrinology 43, 686-688.
20. Kovacs A, Biro E, Szeleczky I & Telegdy G (1995). Role of endogenous CRF in the mediation of neuroendocrine and behavioral responses to calcitonin gene-related peptide in rats. Neuroendocrinology 62, 418-424.
21. Leadem CA & Yagenova SV (1987). Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat. Neuroendocrinology 45, 109-117.
22. Leranth C, MacLusky NJ, Sakamoto H, Shanabrough M & Naftolin F (1985). Glutamic acid decarboxylase-containing axons synapse on LHRH neurons in the rat medial preoptic area. Neuroendocrinology 40, 536-539.
23. Li XF, Bowe JE, Mitchell JC, Brain SD, Lightman SL & O'Byrne KT (2004). Stress-induced suppression of the gonadotropin-releasing hormone pulse generator in the female rat: a novel neural action for calcitonin gene-related peptide. Endocrinology 45, 1556-1563.
24. Li XF, Mitchell JC, Wood S, Coen CW, Lightman SL & O'Byrne KT (2003). The effect of oestradiol and progesterone on hypoglycaemic stress-induced suppression of pulsatile luteinizing hormone release and on corticotropin-releasing hormone mRNA expression in the rat. J Neuroendocrinol 15, 468-476.
25. Lutz TA, Rossi R, Althaus J, Del Prete E & Scharrer E (1998). Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats. Peptides 19, 1533-1540.
26. Maggi R, Pimpinelli F, Martini L & Piva F (1995a). Inhibition of luteinizing hormone-releasing hormone secretion by delta-opioid agonists in GT1-1 neuronal cells. Endocrinology 136, 5177-5181.
27. Maggi R, Pimpinelli F, Martini L & Piva F (1995b). Characterization of functional opioid delta receptors in a luteinizing hormone-releasing hormone-producing neuronal cell line. Endocrinology 136, 289-295.
28. Mallory DS & Gallo RV (1990). Medial preoptic-anterior hypothalamic area involvement in the suppression of pulsatile LH release by a mu-opioid agonist in the ovariectomized rat. Brain Res Bull 25, 251-257.
29. Marko M & Romer D (1983). Inhibitory effect of a new opioid agonist on reproductive endocrine activity in rats of both sexes. Life Sci 33, 233-240.
30. Mitchell V, Prevot V, Jennes L, Aubert JP, Croix D & Beauvillain JC (1997). Presence of mu and kappa opioid receptor mRNAs in galanin but not in GnRH neurons in the female rat. Neuroreport 8, 3167-3172.
31. Monroe SE, Parlow AF & Midgley AR Jr (1968). Radioimmunoassay for rat luteinizing hormone. Endocrinology 83, 1004-1012.
32. O'Byrne KT, Lunn SF & Dixson AF (1989). Naloxone reversal of stress-induced suppression of LH release in the common marmoset. Physiol Behav 45, 1077-1080.
33. Paxinos G & Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
34. Pfeiffer A & Herz A (1984). Endocrine actions of opioids. Horm Metab Res 16, 386-397.
35. Pfeiffer DG, Pfeiffer A, Almeida OF & Herz A (1987). Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion. J Endocrinol 114, 469-476.
36. Pfeiffer DG, Pfeiffer A, Shimohigashi Y, Merriam GR & Loriaux DL (1983). Predominant involvement of mu- rather than delta- or kappa-opiate receptors in LH secretion. Peptides 4, 647-649.
37. Pickel VM, Chan J, Kash TL, Rodriguez JJ & MacKie K (2004). Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127, 101-112.
38. Poore LH & Helmstetter FJ (1996). The effects of central injections of calcitonin gene-related peptide on fear-related behavior. Neurobiol Learn Mem 66, 241-415.
39. Rivest S, Plotsky PM & Rivier C (1993). CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors. Neuroendocrinology 57, 236-246.
40. Rubin BS (1993). Naloxone stimulates comparable release of luteinizing hormone-releasing hormone from tissue fragments from ovariectomizeld, estrogen-treated young and middle-aged female rats. Brain Res 601, 246-254.
41. Sannella MI & Petersen SL (1997). Dual label in situ hybridization studies provide evidence that luteinizing hormone-releasing hormone neurons do not synthesize messenger ribonucleic acid for mu, kappa, or delta opiate receptors. Endocrinology 138, 1667-1672.
42. Sano A, Funabashi T, Kawaguchi M, Shinohara K & Kimura F (1999). Intravenous injections of nicotine decrease the pulsatile secretion of LH by inhibiting the gonadotropin-releasing hormone (GnRH) pulse generator activity in female rats. Psychoneuroendocrinology 24, 397-407.
43. Silva RM, Hadjimarkou MM, Rossi GC, Pasternak GW & Bodnar RJ (2001). β-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J Pharmacol Exp Ther 297, 590-596.
44. Spanagel R, Almeida OF & Shippenberg TS (1994). Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur J Pharmacol 264, 157-162.
45. Thind KK & Goldsmith PC (1988). Infundibular gonadotropin-releasing hormone neurons are inhibited by direct opioid and autoregulatory synapses in juvenile monkeys. Neuroendocrinology 47, 203-216.
46. A receptors in the control of GnRH and beta-endorphin release, and catecholaminergic activity in the preoptic area in anestrous ewes. Exp Clin Endocrinol Diabetes 110, 336-342.
47. Van Cauter E (1988). Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am J Physiol 254, E786-E794.
48. Wang H, Cuzon VC & Pickel VM (2003). Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation. Neuroscience 118, 695-708.